Childhood Cancer Survivors' Knowledge of Diagnosis,Treatment and Risk of Late Effects: Specialized Survivorship Clinic

• interview (Other): * Standard Interview (2-15 years from last treatment) * Demographic data interview (pre-initial study interview)
• clinic visit and interview (Other): * REACH Clinic Visit(initial or regular) * Post-REACH Clinic Interview (3mos from initial or regular clinic visit) * Demographic data interview(pre-initial study interview)
• interviews and clinic visit (Other): * Pre-REACH Clinic Interview(2-15 yrs from last treatment) * REACH Clinic Visit(initial or regular) * Post-REACH Clinic Interview(1mo from initial clinic visit) * Post-REACH Clinic Interview(3mos from initial or regular clinic visit) * Demographic data interview(pre-initial study interview)

Primary outcomes

• Knowledge gained by attending a multispecialty Survivorship Clinic which will be measured by comparison of self report with medical record data in both cross-sectional and longitudinal approach. [12 months]: In addition to data from patient interviews, a review of medical records will include general patient demographic data as well as data regarding cancer diagnosis, treatment and ongoing follow-up care.

Secondary outcomes

• Characterizing how the initial consultation in a specialized clinic impacts childhood cancer survivors' knowledge of their cancer diagnosis, treatment, and risk of late effects by comparing patient's understanding among 3 sampled timepoints. [pre-clinic and a post-clinic interviews at 1 and 3 months.]
• An analysis of differences in relative levels of recommended screening for late effects that childhood cancer survivors have received based on the type of their long-term follow-up care comparing medical records against Survivorship Care Plan. [12 months]: Scored responses will allow for quantitative analysis of differences within and between the cohorts of patients
• A qualitative evaluation of program feedback will serve to improve the care provided in the REACH for Survivorship clinic [12 months]: This data will be evaluated qualitatively for trends.

Sex: All, ages: any to 21 Years

Inclusion Criteria:

* Treatment for primary malignancy per risk-adapted protocol
* Age ≤ 21 years at time of diagnosis
* Currently alive without evidence of disease
* Off therapy for no more than 15 years

Exclusion Criteria:

-Patients who have received a bone marrow transplant